Jeffrey W. Greve serves as Executive at Sagent Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey W. Greve has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 29, 2016 involved selling 4,962 shares valued at $107.9K.
Jeffrey W. Greve currently holds 4,962 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey W. Greve has been a net neutral trader of SGNT stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey W. Greve's most recent insider trade was on Aug 29, 2016, when they sold 4,962 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |